( MENAFN - GlobeNewsWire - Nasdaq) The U.S. antimicrobial susceptibility testing market is projected to grow at a 4.9% CAGR (2025 to 2035), driven by rising antibiotic resistance, advanced healthcare, ...

Tagrisso has been recommended as an adjuvant therapy following complete surgical resection in adults with stage 1B to 3A non-small cell lung cancer (NSCLC) whose tumours have epidermal growth factor ...

Tagrisso has been recommended as an adjuvant therapy following complete surgical resection in adults with stage 1B to 3A non-small cell lung cancer (NSCLC) whose tumours have epidermal growth ...

Both Tagrisso and Imfinzi have been recommended by England’s NICE to treat patients with lung cancer in England and Wales. Credit: Roland Magnusson via Getty Images. AstraZeneca has received two ...

We recently published a list of 15 Hot Tech Stocks to Buy Right Now. In this article, we are going to take a look at where AST SpaceMobile, Inc. (NASDAQ:ASTS) stands against other hot tech stocks ...

We recently published a list of 15 Hot Tech Stocks to Buy Right Now. In this article, we are going to take a look at where AST SpaceMobile, Inc. (NASDAQ:ASTS) stands against other hot tech stocks to ...

AST SpaceMobile announced the placement of $460 million in new convertible debt on Monday. If converted to stock, the new debt will dilute existing shareholders by about 8.5%. This won't be AST's ...

AST SpaceMobile cleared a key regulatory hurdle for its direct-to-device (D2D) service after the Federal Communications Commission (FCC) granted it a special temporary authority (STA) to test its ...

AST Spacemobile, Inc. engages in the building global broadband cellular network in space to operate directly with standard, unmodified mobile devices based on extensive IP and patent portfolio.